Temitayo A Ogunleye, MD
Professor of Clinical Dermatology
Associate Director of Diversity and Inclusion, Department of Dermatology
Director of Penn URIM Visiting Clerkship Program, Department of Dermatology, Penn
GME Ombudsperson, University of Pennsylvania Hospital System
Associate Director, Skin of Color Pre-residency Fellowship, Department of Dermatology
Medical Director (PCAM dermatology), PCAM
Department: Dermatology
Contact information
3400 Civic Center Blvd
7th Floor PCAM South, Room 773
Philadelphia, PA 19104-4283
7th Floor PCAM South, Room 773
Philadelphia, PA 19104-4283
Education:
BS
University of Pittsburgh, 2003.
MD
University of Pennsylvania, 2008.
MHCI (Master's in Health Care Innovation)
University of Pennsylvania, 2021.
Permanent linkBS
University of Pittsburgh, 2003.
MD
University of Pennsylvania, 2008.
MHCI (Master's in Health Care Innovation)
University of Pennsylvania, 2021.
Selected Publications
Alomary SA, Baker NJ, Schell N, Ogunleye T, Taylor S, Milbar H: An Analysis of TSH Levels in Patients with Nonscarring Alopecia: A Single-Center Retrospective Comparative Study. The Journal of Clinical and Aesthetic Dermatology April 2026.Alomary SA, Baker NJ, Ogunleye T, Taylor ST,: Postmarketing safety of bimekizumab for hidradenitis suppurativa: An early pharmacovigilance analysis using the United States Food and Drug Administration Adverse Event Reporting System. JAAD Int 25: 92-94, Apr 2026.
Baker NJ, Alomary SA, Ogunleye T, Taylor S: Risk of Psychiatric Comorbidities in Non-Scarring Versus Scarring Alopecia: A Retrospective Cohort Study. J Cutan Med Surg Apr 2026 Notes: Online ahead of print.
Baker NJ, Alomary SA, Ogunleye T, Taylor S: Risk of Psychiatric Comorbidities in Non-Scarring Versus Scarring Alopecia: A Retrospective Cohort Study. J Cutan Med Surg Apr 2026 Notes: Online ahead of print.
Jackson S, Sidhu K, Durango KP, Hislop C, Obeng-Nyarko CN, Milbar H, Ogunleye TA, Taylor SC: Patient Perspectives and Attitudes Toward the Diagnostic Process for Central Centrifugal Cicatricial Alopecia. J Drugs Dermatol 25(3): 282-85, Mar 2026.
Alomary SA, Baker NJ, Ogunleye T, Taylor SC: Postmarketing safety of bimekizumab for hidradenitis suppurativa: An early pharmacovigilance analysis using the United States Food and Drug Administration Adverse Event Reporting System. JAAD Int 25: 92-94, Feb 2026.
Encarnacion IN, Desir N, Schell N, Mehta A, Ogunleye T, Taylor S: Visit Complexity Differs Between Scarring and Nonscarring Alopecia: A Five-Year DataDerm Analysis. J Am Acad Dermatol S0190-9622(26), Feb 2026 Notes: online ahead of print.
Encarnacion IN, Desir N, Anusionwu ID, Hislop C, Feldman E, Ogunleye T, Taylor S: GLP-1 Receptor Agonists in Overweight and Obese Patients with Hidradenitis Suppurativa. J Drugs Dermatol 25(2): 178-80, Feb 2026.
Ogunleye TA: Patient Perspectives on Scalp Biopsies for CCCA. Journal of Drugs in Dermatology Buzz Series 2026 Notes: https://nextstepsinderm.com/jdd-corner/jdd-buzz-series/jdd-author-buzz-patient-perspectives-on-scalp-biopsies-for-ccca/
Desir N, Encarnacion I, Oyasiji O, Durango K, Obeng-Nyarko C, Ogunleye, Taylor S: Intralesional corticosteroid injection technique for scarring and nonscarring alopecia: A cross-sectional survey of hair experts in the United States. JAAD Aug 2025.